iShares Biotechnology ETF (IBB)
NasdaqGM: IBB
· Echtzeitkurs · USD
198.94
-1.78 (-0.89%)
Zum Schluss: Aug 13, 2026, 3:59 PM
198.95
+0.01%
Nachbörslich: 6:02 PM
iShares Biotechnology ETF (IBB) ETF Price, Holdings & Analysis
-0.89% (1D)
| Geld | 185.09 |
| Marktkapitalisierung | n/a |
| Fondsvermögen | 9.21 Mrd |
| NAV | 199.80 |
| Beta | 0.7 |
| EPS (ttm) | k.A. |
| PE Ratio (ttm) | 25.80 |
| Ausstehende Anteile | 69.7 Mio |
| Auflagedatum | Feb 5, 2001 |
| Brief | 197.12 |
| Volumen | 1,294,749 |
| Ø Vol. (20D) | 1,594,240 |
| Eröffnung | 201.49 |
| Vortagesschluss | 200.72 |
| Tagesspanne | 198.73 - 201.72 |
| 52-Wk Range | 135.68 - 201.72 |
| Positionen | k.A. |
| Kostenquote | 0.44% |
Über IBB
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Anlageklasse Equity
Tickersymbol IBB
Auflagedatum Feb 5, 2001
Anbieter Ishares
Website Fonds-Homepage
Börse NasdaqGM
Top 10 Positionen 46.10% insgesamt
| Name | Symbol | Gewicht |
|---|---|---|
| Amgen Inc | AMGN | 8.51% |
| Vertex Pharmaceutica... | VRTX | 7.93% |
| Gilead Sciences Inc | GILD | 7.21% |
| Regeneron Pharmaceut... | REGN | 6.13% |
| Argenx Se Adr | ARGX | 3.54% |
| Natera Inc | NTRA | 2.91% |
| Revolution Medicines... | RVMD | 2.85% |
| Illumina Inc | ILMN | 2.47% |
| Biogen Inc | BIIB | 2.37% |
| Alnylam Pharmaceutic... | ALNY | 2.18% |
Dividenden Dividendenrendite 0.21%
| Ex-Dividende | Betrag | Zahldatum |
|---|---|---|
| Jun 15, 2026 | $0.0240 | k.A. |
| Mar 17, 2026 | $0.1220 | k.A. |
| Dec 16, 2025 | $0.1830 | k.A. |
| Sep 16, 2025 | $0.0830 | k.A. |
| Mar 18, 2025 | $0.1210 | k.A. |
Seite 1 von 2